Estimating the Direct Medical Costs and Productivity Loss of Outpatient Chlamydia and Gonorrhea Treatment

Sex Transm Dis. 2021 Feb 1;48(2):e18-e21. doi: 10.1097/OLQ.0000000000001240.

Abstract

We used 2016-2017 administrative claims data to calculate the direct medical cost and productivity loss per diagnosed case of chlamydia and gonorrhea treatment. In 2018 US dollars, the direct cost per diagnosed case was $151 for chlamydia (n = 9180) and $85 for gonorrhea (n = 3048); productivity loss was $206 (n = 31) and $246 (n = 7), respectively, among those missing work seeking care.

MeSH terms

  • Chlamydia Infections* / drug therapy
  • Chlamydia Infections* / epidemiology
  • Chlamydia*
  • Costs and Cost Analysis
  • Gonorrhea* / drug therapy
  • Gonorrhea* / epidemiology
  • Humans
  • Outpatients